Comparison of autogenous bone graft donor site haemostatic agents used in spinal surgery

Basit Öğe Kaydı
dc.authoridOzcan, Mert/0000-0002-2009-1881
dc.authorwosidÇiftdemir, Mert/AAH-9210-2020
dc.contributor.authorCopuroglu, Cem
dc.contributor.authorErcan, Selcuk
dc.contributor.authorOzcan, Mert
dc.contributor.authorCiftdemir, Mert
dc.contributor.authorTuran, F. Nesrin
dc.contributor.authorYalniz, Erol
dc.date.accessioned2024-06-12T10:54:59Z
dc.date.available2024-06-12T10:54:59Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: The aim of our study was to investigate the effects of haemostatic agents used at the autograft donor sites in spinal fusion. Methods: The study included 66 patients (26 men, 40 women; mean age: 42.9 years) who underwent spinal fusion surgery between March 1999 and October 2002. Patients were randomly assigned to 4 different groups according to the haemostatic agents used during surgery. In Group 1, bone wax was used on the graft donor site. In Group 2, spongostan was used. In Group 3, spongostan was applied to the donor site and removed after 10 minutes. Group 4 Was the control group and no haemostatic agent was applied. Age, sex, diagnosis and incision shape were not taken into consideration during the selection of patient groups. Closed suction drainage systems were used for the evaluation of drainage amount. The drainage system was removed after 48 hours in patients with a daily drainage of less than 30 cc. Results: In Group 1, there was significantly less drainage than the other groups. Group 2 and Group 3 had less drainage than the control group. When a separate incision was used for graft harvesting, keeping the spongostan at the application site (Group 2) was more effective than its removal (Group 3). Conclusion: The application of bone wax and spongostan to bleeding cancellous bone surfaces at the donor site is a safe and effective method to reduce bleeding and hematoma. Bone wax is more effective than spongostan for haemostasis.en_US
dc.identifier.doi10.3944/AOTT.2011.2420
dc.identifier.endpage364en_US
dc.identifier.issn1017-995X
dc.identifier.issue5en_US
dc.identifier.pmid22033001en_US
dc.identifier.scopus2-s2.0-80055109205en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage359en_US
dc.identifier.urihttps://doi.org/10.3944/AOTT.2011.2420
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19254
dc.identifier.volume45en_US
dc.identifier.wosWOS:000208713300012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Assoc Orthopaedics Traumatologyen_US
dc.relation.ispartofActa Orthopaedica Et Traumatologica Turcicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBone Waxen_US
dc.subjectDrainen_US
dc.subjectHaemostatic Agenten_US
dc.subjectSpongostanen_US
dc.subjectGelfoam Pasteen_US
dc.subjectDrainsen_US
dc.titleComparison of autogenous bone graft donor site haemostatic agents used in spinal surgeryen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu